10-Q: Bellevue Life Sciences Acquisition Corp. Reports Q3 2024 Results, Faces Ongoing Listing Challenges

Bellevue Life Sciences Acquisition Corp. reported a net loss for the third quarter of 2024 and is navigating ongoing challenges with Nasdaq listing requirements while pursuing a business combination.

Summary

• Bellevue Life Sciences Acquisition Corp. (BLAC) reported a net loss of $230,961 for the three months ended September 30, 2024, compared to a net income of $78,183 for the same period in 2023.
• The company's operating expenses were $454,132 for the quarter, with interest income from the trust account partially offsetting this at $269,204.
• For the nine months ended September 30, 2024, BLAC reported a net loss of $388,686, compared to a net income of $489,952 for the same period in 2023.
• The company's cash balance was $12,236 as of September 30, 2024, with a working capital deficit of $3,901,465.
• BLAC has been extending the deadline to complete a business combination, with the current deadline being February 14, 2025, subject to stockholder approval.
• The company has faced challenges with Nasdaq listing requirements, specifically regarding the minimum number of public holders, and has been granted an extension until February 17, 2025, to demonstrate compliance.
• BLAC has entered into a subscription agreement with Toonon Partners Co., Ltd. for a $20 million PIPE investment, contingent on the closing of the business combination.
• The company has also issued several promissory notes to related parties to fund operations and extend the business combination deadline.

Sentiment

Score: 3

Explanation: The document presents a concerning financial situation with a net loss, low cash balance, and a working capital deficit. The company is also facing significant challenges with Nasdaq listing requirements and is reliant on related party funding. While there is a PIPE investment, it is contingent on the business combination, which is not guaranteed. The overall sentiment is negative due to the numerous risks and uncertainties.

Positives

• The company has secured a $20 million PIPE investment from Toonon Partners Co., Ltd., which will provide working capital after the business combination.
• BLAC has been granted an extension by Nasdaq to regain compliance with the minimum public holder requirement until February 17, 2025.
• The company has successfully extended the deadline to complete a business combination to February 14, 2025, providing more time to finalize a deal.

Negatives

• BLAC reported a net loss of $230,961 for Q3 2024, a significant decrease from the net income of $78,183 in Q3 2023.
• The company has a working capital deficit of $3,901,465 as of September 30, 2024.
• BLAC is not in compliance with Nasdaq's minimum public holder requirement, which could lead to delisting.
• The company has incurred significant redemptions of common stock, reducing the funds available in the trust account.
• The company's cash balance is very low at $12,236 as of September 30, 2024.
• The company has issued a significant amount of promissory notes to related parties, indicating a reliance on related party funding.

Risks

• The company's ability to continue as a going concern is in doubt due to its low cash balance and working capital deficit.
• Failure to regain compliance with Nasdaq's minimum public holder requirement could result in delisting.
• The business combination is subject to several conditions, including a minimum cash requirement, which may not be met.
• The company is reliant on related party loans to fund operations, which may not be sustainable.
• The company may be deemed an investment company under the Investment Company Act, which would severely restrict its activities.
• The company faces risks related to the ongoing Russia-Ukraine conflict and the recent escalation of the Israel-Hamas conflict, which could impact its search for a business combination.

Future Outlook

The company is focused on completing a business combination by February 14, 2025, and is working to regain compliance with Nasdaq listing requirements. The company has secured a $20 million PIPE investment contingent on the closing of the business combination.

Management Comments

• Management believes that the Company will not have sufficient working capital to meet its needs through the earlier of the consummation of an Initial Business Combination or February 14, 2025.
• Management intends to complete a business combination.

Industry Context

The document reflects the challenges faced by many SPACs in the current market, including difficulties in finding suitable merger targets, maintaining listing compliance, and managing redemptions. The company's reliance on related party funding is also a common theme among SPACs facing time constraints.

Comparison to Industry Standards

• The financial performance of BLAC is below average compared to other SPACs, with a net loss and a significant working capital deficit.
• The high redemption rate of common stock is a common issue for SPACs, but BLAC's rate is particularly high, indicating a lack of investor confidence.
• The company's struggle to maintain Nasdaq listing compliance is also a common issue for SPACs, but the repeated extensions and non-compliance notices are concerning.
• The reliance on related party loans is not uncommon for SPACs, but the amount of debt BLAC has accumulated is higher than average.
• The $20 million PIPE investment is a positive sign, but it is contingent on the closing of the business combination, which is not guaranteed.
• Compared to other SPACs, BLAC's timeline for completing a business combination is extended, indicating potential difficulties in finding a suitable target.

Related Party Transactions

• The company has issued several promissory notes to related parties, including the Sponsor, Jun Chul Whang, and Josh Pan.
• The company pays an affiliate of the Sponsor $7,500 per month for administrative support.
• The company has a due to affiliate balance of $87,000 as of September 30, 2024.

Stakeholder Impact

• Shareholders face the risk of losing their investment if the company is unable to complete a business combination or is delisted from Nasdaq.
• Employees may be impacted by the uncertainty surrounding the company's future.
• Creditors face the risk of not being repaid if the company is unable to complete a business combination.
• The company's suppliers may be impacted by the company's financial difficulties.

Next Steps

• The company needs to complete a business combination by February 14, 2025.
• The company needs to regain compliance with Nasdaq's minimum public holder requirement by February 17, 2025.
• The company needs to close the PIPE investment with Toonon Partners Co., Ltd.
• The company needs to manage its working capital deficit and low cash balance.

Key Dates

Keywords

SPAC, Business Combination, Nasdaq Listing, Redemption, Promissory Notes, PIPE Investment, Working Capital, Financial Results, Going Concern, OSR Holdings